Synchronisation and control of proliferation in cycling cell population models with age structure

We present and analyse in this article a mathematical question with a biological origin, the theoretical treatment of which may have far-reaching implications in the practical treatment of cancers. Starting from biological and clinical observations on cancer cells, tumour-bearing laboratory rodents, and patients with cancer, we ask from a theoretical biology viewpoint questions that may be transcribed, using physiologically based modelling of cell proliferation dynamics, into mathematical questions. We then show how recent fluorescence-based image modelling techniques performed at the single cell level in proliferating cell populations allow to identify model parameters and how this may be applied to investigate healthy and cancer cell populations. Finally, we show how this modelling approach allows us to design original optimisation methods for anticancer therapeutics, in particular chronotherapeutics, by controlling eigenvalues of the differential operators underlying the cell proliferation dynamics, in tumour and in healthy cell populations. We propose a numerical algorithm to implement these principles.

[1]  Akif Uzman,et al.  The cell cycle: Principles of control (Primers in Biology series) , 2007 .

[2]  Jean Clairambault,et al.  Comparison of Perron and Floquet Eigenvalues in Age Structured Cell Division Cycle Models , 2008, 0812.0803.

[3]  Jean Charles Gilbert,et al.  Numerical Optimization: Theoretical and Practical Aspects , 2003 .

[4]  Francis Lévi,et al.  Chronotherapeutics: The Relevance of Timing in Cancer Therapy , 2006, Cancer Causes & Control.

[5]  S. Reppert,et al.  Coordination of circadian timing in mammals , 2002, Nature.

[6]  A. Goldstein Convex programming in Hilbert space , 1964 .

[7]  Jean Clairambault,et al.  Analysis of a molecular structured population model with possible polynomial growth for the cell division cycle , 2008, Math. Comput. Model..

[8]  M. Ffrench,et al.  Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. , 1998, Experimental cell research.

[9]  F. Lévi,et al.  The Circadian Timing System: A Coordinator of Life Processes [Chronobiological Investigations] , 2008, IEEE Engineering in Medicine and Biology Magazine.

[10]  I. Tannock,et al.  ON THE EXISTENCE OF A Go‐PHASE IN THE CELL CYCLE , 1970 .

[11]  A. Arkin,et al.  Stochastic mechanisms in gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Robert H. Halstead,et al.  Matrix Computations , 2011, Encyclopedia of Parallel Computing.

[13]  Marek Kimmel,et al.  Comparison of Approaches to Modeling of Cell Population Dynamics , 1993, SIAM J. Appl. Math..

[14]  Mats Gyllenberg,et al.  The inverse problem of linear age-structured population dynamics , 2002 .

[15]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[16]  Albert Goldbeter,et al.  Implications of circadian clocks for the rhythmic delivery of cancer therapeutics , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[17]  Stefano Iacobelli,et al.  Elevated Serum Cytokines Correlated with Altered Behavior, Serum Cortisol Rhythm, and Dampened 24-Hour Rest-Activity Patterns in Patients with Metastatic Colorectal Cancer , 2005, Clinical Cancer Research.

[18]  Dimitri P. Bertsekas,et al.  Nonlinear Programming , 1997 .

[19]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[20]  B. Henderson-Sellers,et al.  Mathematics and Computers in Simulation , 1995 .

[21]  Allen A. Goldstein,et al.  Constructive Real Analysis , 1967 .

[22]  David O. Morgan,et al.  The Cell Cycle: Principles of Control , 2014 .

[23]  Ovide Arino,et al.  A survey of structured cell population dynamics , 1995, Acta biotheoretica.

[24]  W J Hrushesky,et al.  Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. , 2001, The American journal of pathology.

[25]  Ueli Schibler,et al.  Circadian rhythms: mechanisms and therapeutic implications. , 2007, Annual review of pharmacology and toxicology.

[26]  D. P. King,et al.  Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. , 1994, Science.

[27]  A. M'Kendrick Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.

[28]  J. Frédéric Bonnans,et al.  Numerical Optimization: Theoretical and Practical Aspects (Universitext) , 2006 .

[29]  Francis Lévi,et al.  From circadian rhythms to cancer chronotherapeutics , 2002, Chronobiology international.

[30]  Laurent Pujo-Menjouet,et al.  Analysis of cell kinetics using a cell division marker: mathematical modeling of experimental data. , 2003, Biophysical journal.

[31]  Kendrick,et al.  Applications of Mathematics to Medical Problems , 1925, Proceedings of the Edinburgh Mathematical Society.

[32]  H. M. Pinedo,et al.  Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma , 2004, Cancer Chemotherapy and Pharmacology.

[33]  O D Laerum,et al.  DNA synthesis in human bone marrow is circadian stage dependent. , 1991, Blood.

[34]  R G Staudte,et al.  Planning blocked mitosis experiments for efficient estimation of population-doubling time and cell-cycle time. , 1982, Biometrics.

[35]  B. Perthame Transport Equations in Biology , 2006 .

[36]  R J Konopka,et al.  Clock mutants of Drosophila melanogaster. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D K Smith,et al.  Numerical Optimization , 2001, J. Oper. Res. Soc..

[38]  J Lellouch,et al.  Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  A. Kalsbeek,et al.  Hypothalamic integration of central and peripheral clocks , 2001, Nature Reviews Neuroscience.

[40]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[41]  Albert Goldbeter,et al.  Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[42]  C. Weitz,et al.  Regulation of Daily Locomotor Activity and Sleep by Hypothalamic EGF Receptor Signaling , 2001, Science.

[43]  Franck Delaunay,et al.  The Circadian Clock Component BMAL1 Is a Critical Regulator of p21WAF1/CIP1 Expression and Hepatocyte Proliferation* , 2008, Journal of Biological Chemistry.

[44]  I. Tannock,et al.  On the existence of a G 0 -phase in the cell cycle. , 1970, Cell and tissue kinetics.

[45]  F. Lévi,et al.  The circadian timing system, a coordinator of life processes. implications for the rhythmic delivery of cancer therapeutics , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[46]  Olivier Fercoq,et al.  Optimisation of Cancer Drug Treatments Using Cell Population Dynamics , 2013 .

[47]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[48]  Jack Yurkiewicz,et al.  Constrained optimization and Lagrange multiplier methods, by D. P. Bertsekas, Academic Press, New York, 1982, 395 pp. Price: $65.00 , 1985, Networks.

[49]  Jean Clairambault,et al.  An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations , 2007, 0704.3820.

[50]  Francis Lévi,et al.  Host circadian clock as a control point in tumor progression. , 2002, Journal of the National Cancer Institute.

[51]  B. Perthame,et al.  General entropy equations for structured population models and scattering , 2004 .

[52]  Albert Goldbeter,et al.  A cell cycle automaton model for probing circadian patterns of anticancer drug delivery. , 2007, Advanced drug delivery reviews.

[53]  G Böck,et al.  Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells , 2004, Cell Death and Differentiation.

[54]  V. A. Stewart,et al.  Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya , 2009, PloS one.

[55]  P Ubezio,et al.  Desynchronization rate in cell populations: mathematical modeling and experimental data. , 2001, Journal of theoretical biology.

[56]  Jean Clairambault,et al.  Optimizing cancer pharmacotherapeutics using mathematical modeling and a systems biology approach. , 2011, Personalized medicine.

[57]  G. Yarrington Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.

[58]  Stéphane Gaubert,et al.  Circadian rhythm and cell population growth , 2010, Math. Comput. Model..

[59]  Philippe Michel,et al.  Circadian rhythm and tumour growth , 2006 .

[60]  R. Jordan,et al.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium. , 1999, The American journal of pathology.

[61]  M. Overton,et al.  On minimizing the spectral radius of a nonsymmetric matrix function: optimality conditions and duality theory , 1988 .

[62]  Jean Clairambault,et al.  A mathematical model of the cell cycle and its control , 2003 .

[63]  Paolo Sassone-Corsi,et al.  A Web of Circadian Pacemakers , 2002, Cell.

[64]  Stefano Iacobelli,et al.  Effects of light and food schedules on liver and tumor molecular clocks in mice. , 2005, Journal of the National Cancer Institute.

[65]  Jean Clairambault,et al.  A Step Toward Optimization of Cancer Therapeutics , 2008 .

[66]  D. Bertsekas On the Goldstein-Levitin-Polyak gradient projection method , 1974, CDC 1974.

[67]  Albert Goldbeter,et al.  An automaton model for the cell cycle , 2011, Interface Focus.

[68]  O. Arino,et al.  A Survey of Cell Population Dynamics , 1997 .

[69]  Samuel Bernard,et al.  Tumor Growth Rate Determines the Timing of Optimal Chronomodulated Treatment Schedules , 2010, PLoS Comput. Biol..

[70]  John Jeremy Rice,et al.  A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Jean Clairambault,et al.  Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments , 2009 .

[72]  Alexander Shapiro,et al.  On Eigenvalue Optimization , 1995, SIAM J. Optim..

[73]  Wei Wang,et al.  Two-phase dynamics of p53 in the DNA damage response , 2011, Proceedings of the National Academy of Sciences.

[74]  Andrzej Swierniak,et al.  Control Theory Approach to Cancer Chemotherapy: Benefiting from Phase Dependence and Overcoming Drug Resistance , 2006 .

[75]  T. Lepoutre,et al.  Analyse et modélisation de phénomènes de croissance et mouvement issus de la biologie , 2009 .

[76]  Francis Levi Cancer chronotherapeutics , 1998 .

[77]  Jean Clairambault,et al.  Circadian timing in cancer treatments. , 2010, Annual review of pharmacology and toxicology.

[78]  Peng Huang,et al.  The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo , 2002, Cell.

[79]  Tosio Kato Perturbation theory for linear operators , 1966 .

[80]  Atsushi Miyawaki,et al.  Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression , 2008, Cell.

[81]  Pierre Gabriel,et al.  The contribution of age structure to cell population responses to targeted therapeutics. , 2011, Journal of theoretical biology.

[82]  Jean Clairambault,et al.  Modeling oxaliplatin drug delivery to circadian rhythms in drug metabolism and host tolerance. , 2007, Advanced drug delivery reviews.

[83]  R. Milo,et al.  Protein Dynamics in Individual Human Cells: Experiment and Theory , 2009, PloS one.

[84]  O. Diekmann,et al.  The Dynamics of Physiologically Structured Populations , 1986 .

[85]  K. Calman,et al.  Immunological Aspects of Cancer Chemotherapy , 1980 .

[86]  F. Innocenti,et al.  Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[87]  Robert B. Diasio,et al.  Clinical Pharmacology of 5-Fluorouracil , 1989, Clinical pharmacokinetics.

[88]  Claude Basdevant,et al.  Optimisation of time-scheduled regimen for anti-cancer drug infusion , 2005 .

[89]  S. Yamaguchi,et al.  Control Mechanism of the Circadian Clock for Timing of Cell Division in Vivo , 2003, Science.

[90]  J. Cicenas,et al.  The CDK inhibitors in cancer research and therapy , 2011, Journal of Cancer Research and Clinical Oncology.

[91]  Jean Clairambault,et al.  An age-and-cyclin-structured cell population model for healthy and tumoral tissues , 2008, Journal of mathematical biology.

[92]  Paul Brazhnik,et al.  Exploring Mechanisms of the DNA-Damage Response: p53 Pulses and their Possible Relevance to Apoptosis , 2007, Cell cycle.

[93]  Vahid Shahrezaei,et al.  Analytical distributions for stochastic gene expression , 2008, Proceedings of the National Academy of Sciences.

[94]  E. Sherer,et al.  Identification of age‐structured models: Cell cycle phase transitions , 2008, Biotechnology and bioengineering.

[95]  Michael L. Overton,et al.  Large-Scale Optimization of Eigenvalues , 1990, SIAM J. Optim..

[96]  Atsushi Miyawaki,et al.  Tracing the silhouette of individual cells in S/G2/M phases with fluorescence. , 2008, Chemistry & biology.

[97]  B. Perthame,et al.  General relative entropy inequality: an illustration on growth models , 2005 .

[98]  Dominik Wodarz,et al.  Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Robert J. Plemmons,et al.  Nonnegative Matrices in the Mathematical Sciences , 1979, Classics in Applied Mathematics.